Android app Apple app link

Rhythm Pharmaceuticals, Inc. (RYTM) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$113.56

$4.06 (-3.45%)
Last update: 04:00 PM EST
Day's range
$109.59
Day's range
$119.58

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/12/2025 Canaccord Genuity Whitney Ijem $141.00 $117.52   19.98%
10/17/2025 Goldman Sachs Corinne Johnson $139.00 $111.18   25.02%
09/29/2025 H.C. Wainwright Raghuram Selvaraju $110.00 $99.16   10.93%
09/25/2025 JMP Securities Jonathan Wolleben $142.00 $98.76   43.78%
07/10/2025 Oppenheimer Leland Gershell $110.00 $89.04   23.54%
07/10/2025 Goldman Sachs Corinne Johnson $97.00 $89.04   8.94%
07/09/2025 Morgan Stanley Michael Ulz $95.00 $89.00   6.74%
01/01/2025 Jefferies Dennis Ding $80.00 $55.98   42.91%
12/05/2024 Goldman Sachs Corinne Jenkins $66.00 $60.02   9.97%
11/06/2024 Needham Alan Carr $64.00 $55.79   14.73%
11/06/2024 Goldman Sachs Corinne Jenkins $59.00 $55.79   5.76%
09/18/2024 H.C. Wainwright Raghuram Selvaraju $64.00 $53.17   20.37%
09/16/2024 JMP Securities Jonathan Wolleben $64.00 $54.00   18.52%
07/25/2024 Needham Alan Carr $55.00 $49.61   10.86%
08/07/2022 Goldman Sachs Corinne Jenkins $28.00 $20.24   38.34%
07/12/2022 Goldman Sachs Corinne Jenkins $6.00 $6.38   -5.96%
06/17/2022 Stifel Nicolaus Dae Gon Ha $25.00 $3.90   541.03%

Rhythm Pharmaceuticals, Inc. FAQ's

Rhythm Pharmaceuticals, Inc. has been rated by research analysts at Goldman Sachs, Canaccord Genuity, Morgan Stanley, H.C. Wainwright, JMP Securities, Oppenheimer in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.